Literature DB >> 2720316

Mortality and perforated peptic ulcer: a case for risk stratification in elderly patients.

T T Irvin1.   

Abstract

In a consecutive series of 284 patients with a perforated peptic ulcer (229 pyloroduodenal, 55 gastric) there was a 26 per cent hospital mortality rate, and patients aged greater than or equal to 70 years (n = 176) had a significantly higher mortality rate (34 per cent) than patients aged less than 70 years (14 per cent, P less than 0.001). Multiple clinical variables were significantly more common in the elderly group of patients (65 per cent), in those having non-steroidal anti-inflammatory drugs or steroid therapy (56 per cent), in patients where there is an absence of a previous dyspeptic history (69 per cent), and when risk factors such as delayed presentation (33 per cent) and the presence of shock on admission to hospital (27 per cent) are present. Definitive operations (vagotomy or gastrectomy) had an increased mortality rate in the elderly (P = 0.018). Risk scores based upon the presence of shock, delayed presentation or concurrent medical illness could have predicted 87 per cent of postoperative deaths in elderly subjects, and it is suggested that risk stratification and greater caution in the use of definitive operations for perforated ulcer may result in a reduction in the high mortality rate in elderly subjects.

Entities:  

Mesh:

Year:  1989        PMID: 2720316     DOI: 10.1002/bjs.1800760304

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  20 in total

1.  Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer.

Authors:  Mario Testini; Piero Portincasa; Giuseppe Piccinni; Germana Lissidini; Fabio Pellegrini; Luigi Greco
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Triple-ostomy: management of perforations to the second part of the duodenum in patients unfit for definitive surgery.

Authors:  P J J Herrod; D Kamali; S C B Pillai
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 4.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

5.  Adverse effects of delayed treatment for perforated peptic ulcer.

Authors:  C Svanes; R T Lie; K Svanes; S A Lie; O Søreide
Journal:  Ann Surg       Date:  1994-08       Impact factor: 12.969

6.  Influence of age, comorbidity, type of operation and other variables on lethality and duration of post-operative hospital stay in patients with peptic ulcer. An analysis of 303 surgically treated patients.

Authors:  J Högel; R J Rieker; R Eisele; E Schmid
Journal:  Langenbecks Arch Chir       Date:  1996

7.  Scoring Systems for Outcome Prediction of Patients with Perforation Peritonitis.

Authors:  Murugappan Nachiappan; Manjusha Madhusudhan Litake
Journal:  J Clin Diagn Res       Date:  2016-03-01

8.  Perforated peptic ulcer: main factors of morbidity and mortality.

Authors:  Carlos Noguiera; António Sérgio Silva; Jorge Nunes Santos; António Gomes Silva; Joaquim Ferreira; Eduarda Matos; Hernani Vilaça
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

9.  The acute surgical admission: is mortality predictable in the elderly?

Authors:  R H Kennedy; R A al-Mufti; S F Brewster; E N Sherry; T R Magee; T T Irvin
Journal:  Ann R Coll Surg Engl       Date:  1994-09       Impact factor: 1.891

10.  Perforated peptic ulcer and short-term mortality among tramadol users.

Authors:  Marie L Tørring; Anders Riis; Steffen Christensen; Reimar W Thomsen; Peter Jepsen; Jens Søndergaard; Henrik T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.